Joan Shaw
Chief Tech/Sci/R&D Officer chez BELLUS HEALTH
Profil
Joan E.
Shaw is currently the Vice President-Clinical Operations at BELLUS Health, Inc. Prior to this, she worked as the Senior Director-Clinical Operations at AtheroNova, Inc. She completed her undergraduate degree at the University of Delaware and her graduate degree at West Chester University of Pennsylvania.
Postes actifs de Joan Shaw
| Sociétés | Poste | Début |
|---|---|---|
| BELLUS HEALTH | Chief Tech/Sci/R&D Officer | 01/03/2020 |
Anciens postes connus de Joan Shaw
| Sociétés | Poste | Fin |
|---|---|---|
| ATHERONOVA INC. | Chief Tech/Sci/R&D Officer | - |
Formation de Joan Shaw
| University of Delaware | Undergraduate Degree |
| West Chester University of Pennsylvania | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
BELLUS Health, Inc.
 BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. | Health Technology |
AtheroNova, Inc.
 AtheroNova, Inc. Pharmaceuticals: MajorHealth Technology AtheroNova, Inc. operates as biotechnology company. The company engages in the research and development, marketing, and sale of pharmaceutical preparations and pharmaceutical intellectual property. It develops intellectual property that uses certain pharmacological compounds for the treatment of atherosclerosis, which is the primary cause of various cardiovascular diseases. The company was founded by Giorgio Zadini and Filiberto Zadini in 1997 and is headquartered in Irvine, CA. | Health Technology |
